Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 256.00 (1.82%)

Bid:

14,256.00

Ask:

14,262.00

Spread: 6.00 (0.042%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

LONDON BRIEFING: Harbour Energy makes USD3.2 billion US buy

(Alliance News) - Harbour Energy has struck a deal to deliver on a "long-standing ambition", while AstraZeneca reports a drug failed to meet its prima...

Trump, nine pharmaceutical companies strike deal to cut prices

Drugmakers to cut prices on most drugs sold to the Medicaid program *

Several top drugmakers to lower US prices for some drugs-sources

Dec 19 (Reuters) - ‌AbbVie, Bristol Myers Squibb, Gilead, Merck and ⁠other drugmakers are expected on Friday afternoon to announce agreements with t...

Daiichi Sankyo, AstraZeneca apply for second EU approval for Datroway

(Alliance News) - Daiichi Sankyo Co Ltd on Thursday said the EU has validated an application for Datroway as a first-line treatment for patients with ...

Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal

ZURICH, Dec 18 (Reuters) - Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with th...

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17 (Reuters) - AbbVie and several other drugmakers are expected to announce on Friday agreements with the U.S. government to lower certain presc...

AstraZeneca's Saphnelo gets EU approval for self-administration

(Alliance News) - AstraZeneca PLC on Tuesday said its drug Saphnelo, or anifrolumab, has been approved in the European Union as a new pre-filled pen f...

AstraZeneca chalks up dual regulatory wins in cancer and immunology

(Sharecast News) - Drugmaker AstraZeneca chalked up two regulatory wins on Tuesday, with approvals in both the US and Europe for key treatments in onc...